Comparing the Efficacy of Nab-PHP and TCbHP in Neoadjuvant Therapy for HER2 Positive Operable Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer,Her2 Positive
Interventions: DRUG: Albumin binding paclitaxel+ trastuzumab+ patuzumab|DRUG: Docetaxel+ carboplatin+ trastuzumab + patuzumab
Sponsor: Henan Cancer Hospital